Brown, Lisle/Cummings, Inc. Ark Genomic Revolution ETF (De Transaction History

Brown, Lisle/Cummings, Inc.

  • $335 Billion
  • Q4 2024

A detailed history of Brown, Lisle/Cummings, Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 400 shares of ARKG stock, worth $9,100. This represents 0.0% of its overall portfolio holdings.

Number of Shares
400
Previous 379 5.54%
Holding current value
$9,100
Previous $9.7 Million 2.93%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025
BUY
$22.66 - $27.11 $475 - $569
21 Added 5.54%
400 $9.42 Million
Q2 2024

Jul 17, 2024
BUY
$23.01 - $28.35 $2,968 - $3,657
129 Added 51.6%
379 $8.9 Million
Q1 2023

Jun 28, 2024
BUY
$27.46 - $36.49 $2,059 - $2,736
75 Added 42.86%
250 $7.52 Million
Q4 2022

Jun 28, 2024
BUY
$27.08 - $36.23 $2,030 - $2,717
75 Added 75.0%
175 $4.94 Million
Q1 2022

Jun 28, 2024
BUY
$38.15 - $63.26 $3,815 - $6,326
100 New
100 $4.59 Million

Others Institutions Holding ARKG

# of Institutions
288
Shares Held
23.4M
Call Options Held
2.91M
Put Options Held
2.5M
View Full List

About ARK GENOMIC REVOLUTION ETF (DE

ARKG Quotes by TradingView
  • Ticker ARKG
  • Sector ETFs
  • Industry ETFs
More about ARKG
Track This Portfolio

Track Brown, Lisle/Cummings, Inc. Portfolio

Follow Brown, Lisle/Cummings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown, Lisle/Cummings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brown, Lisle/Cummings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email